Retigabine (Ezogabine) is an anticonvulsant medication classified as a neuronal potassium channel opener, primarily used as adjunctive therapy for the treatment of partial-onset seizures. This category… Read more






Retigabine (Ezogabine) is an anticonvulsant medication classified as a neuronal potassium channel opener, primarily used as adjunctive therapy for the treatment of partial-onset seizures. This category offers high-quality reference standards, including Retigabine Dihydrochloride, alongside its related metabolites and impurities such as N-acetyl retigabine and various dihydrochloride impurity forms. Pharmaceutical laboratories utilize these compounds for comprehensive impurity profiling, method validation, and rigorous quality control protocols. The inclusion of stable isotope labelled compounds, such as Retigabine-d5 and N-acetyl retigabine-d5, provides essential internal standards for quantifying drug concentrations and verifying analytical accuracy in complex matrices. By maintaining a consistent supply of these validated materials, researchers and analysts can ensure the precision and reliability of their testing procedures throughout the drug development and manufacturing lifecycle.